{
  "metadata": {
    "case_id": 85,
    "model": "Claude-4.5-Sonnet",
    "timestamp": "2025-11-29T19:19:15.853509",
    "total_alignments": 2,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/85_NCT02740231.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/Claude-4.5-Sonnet/85_Claude-4.5-Sonnet.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 4,
      "pred_count": 4,
      "similarity_matrix": [
        [
          0.35,
          0.6,
          0.41,
          0.83
        ],
        [
          0.86,
          0.82,
          0.78,
          0.3
        ],
        [
          0.82,
          0.82,
          0.86,
          0.58
        ],
        [
          0.9,
          0.78,
          0.82,
          0.32
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 3,
          "score": 0.83,
          "status": "matched",
          "ref_item": {
            "label": "Reference product",
            "type": "ACTIVE_COMPARATOR",
            "description": "Hylan G-F 20",
            "interventionNames": [
              "Device: Reference product intra-articular injection"
            ]
          },
          "pred_item": {
            "label": "Reference",
            "type": "ACTIVE_COMPARATOR",
            "description": "Group of patients receiving a single intra-articular injection of the reference treatment (hylan G-F 20, Synvisc-One®) containing 48 mg sodium hyaluronate in 6 ml volume",
            "interventionNames": [
              "BIOLOGICAL: Hylan G-F 20"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 1,
          "score": 0.82,
          "status": "matched",
          "ref_item": {
            "label": "JTA-004 50 (2 ml)",
            "type": "EXPERIMENTAL",
            "description": "Sodium hyaluronate, plasma proteins and clonidine",
            "interventionNames": [
              "Drug: JTA-004 intra-articular injection"
            ]
          },
          "pred_item": {
            "label": "JTA-200/2",
            "type": "EXPERIMENTAL",
            "description": "Group of patients receiving a single intra-articular injection of JTA-004 formulation containing 200 μg clonidine and 20 mg hyaluronic acid in 2 ml volume",
            "interventionNames": [
              "BIOLOGICAL: JTA-200/2"
            ]
          }
        },
        {
          "ref_idx": 2,
          "pred_idx": 2,
          "score": 0.86,
          "status": "matched",
          "ref_item": {
            "label": "JTA-004 50 (4 ml)",
            "type": "EXPERIMENTAL",
            "description": "Sodium hyaluronate, plasma proteins and clonidine",
            "interventionNames": [
              "Drug: JTA-004 intra-articular injection"
            ]
          },
          "pred_item": {
            "label": "JTA-200/4",
            "type": "EXPERIMENTAL",
            "description": "Group of patients receiving a single intra-articular injection of JTA-004 formulation containing 200 μg clonidine and 40 mg hyaluronic acid in 4 ml volume",
            "interventionNames": [
              "BIOLOGICAL: JTA-200/4"
            ]
          }
        },
        {
          "ref_idx": 3,
          "pred_idx": 0,
          "score": 0.9,
          "status": "matched",
          "ref_item": {
            "label": "JTA-004 100 (2 ml)",
            "type": "EXPERIMENTAL",
            "description": "Sodium hyaluronate, plasma proteins and clonidine",
            "interventionNames": [
              "Drug: JTA-004 intra-articular injection"
            ]
          },
          "pred_item": {
            "label": "JTA-100/2",
            "type": "EXPERIMENTAL",
            "description": "Group of patients receiving a single intra-articular injection of JTA-004 formulation containing 100 μg clonidine and 20 mg hyaluronic acid in 2 ml volume",
            "interventionNames": [
              "BIOLOGICAL: JTA-100/2"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.interventions",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 4,
      "similarity_matrix": [
        [
          0.88,
          0.86,
          0.88,
          0.62
        ],
        [
          0.7,
          0.4,
          0.5,
          0.78
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.88,
          "status": "matched",
          "ref_item": {
            "type": "DRUG",
            "name": "JTA-004 intra-articular injection",
            "description": "Each patient will undergo a single injection of JTA-004 into the knee joint",
            "armGroupLabels": [
              "JTA-004 100 (2 ml)",
              "JTA-004 50 (2 ml)",
              "JTA-004 50 (4 ml)"
            ]
          },
          "pred_item": {
            "type": "BIOLOGICAL",
            "name": "JTA-100/2",
            "description": "Single intra-articular injection of JTA-004 formulation containing 2.04 g plasma protein solution (1.02 g/ml concentration), 100 μg clonidine (50 μg/ml concentration), and 20 mg hyaluronic acid (10 mg/ml concentration) in 2 ml volume. Provided as freeze-dried powder for solution to be reconstituted with sterile water before injection.",
            "armGroupLabels": [
              "JTA-100/2"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 3,
          "score": 0.78,
          "status": "matched",
          "ref_item": {
            "type": "DEVICE",
            "name": "Reference product intra-articular injection",
            "description": "Each patient will undergo a single injection of Reference product into the knee joint",
            "armGroupLabels": [
              "Reference product"
            ]
          },
          "pred_item": {
            "type": "BIOLOGICAL",
            "name": "Hylan G-F 20",
            "description": "Single intra-articular injection of hylan G-F 20 (Synvisc-One®, Sanofi, France) containing 48 mg sodium hyaluronate in 6 ml volume. Provided as a sterile viscoelastic solution in a ready-to-use syringe.",
            "armGroupLabels": [
              "Reference"
            ]
          }
        }
      ]
    }
  ]
}